Biotinylated, irradiated and 51-Chromium radiolabeled red blood cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biotinylated, irradiated and 51-Chromium radiolabeled red blood cells, covering 2026-04-16 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion [Phase 1]